(Bloomberg) — CVS Health Corp. was accused in a lawsuit by pharmacy customers of intentionally overcharging for generic prescription drugs by submitting claims for payment to third parties at inflated prices.
Beginning in 2008, CVS orchestrated a "massive fraud that resulted in substantial ill-gotten gains," according to the complaint filed Thursday in San Francisco federal court. The drugstore chain sometimes charges three or four times the customary price for generic drugs, the customers said.
The lawsuit's allegations involve the company's Health Savings Pass, a discount program for patients paying cash for prescriptions. Customers who buy prescriptions through third-party plans pay higher prices than those paying cash, according to the complaint.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
